Caissa Capital Management ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), bought 17,500 shares at $3.08 ($54K) on 2023-04-20, disclosed to the SEC on 2023-04-24.
Open-market purchase of $54k AVTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.08 | 5,000 | $15K | 28.7% |
| 2 | $3.06 | 12,500 | $38K | 71.3% |
| Total | $3.07 avg | 17,500 | $54K | 100% |
| Filing → |
| AVTX | BUY | 2023-06-14 | $64K | — | Filing → |
| AVTX | BUY | 2023-06-09 | $56K | — | Filing → |
| AVTX | BUY | 2023-06-02 | $2K | — | Filing → |